GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
106 hedge funds and large institutions have $368M invested in GenMark Diagnostics, Inc in 2019 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 41 increasing their positions, 28 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
106
Holders Change
+3
Holders Change %
+2.91%
% of All Funds
2.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
41
Reduced
28
Closed
11
Calls
–
Puts
$74K
Net Calls
-$74K
Net Calls Change
-$15K
Top Buyers
| 1 |
Millennium Management
New York
|
+$2.98M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$2.51M |
| 3 |
Goldman Sachs
New York
|
+$2.03M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.79M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$1.6M |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
-$10.4M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$4.23M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.39M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.21M |
| 5 |
CC
Casdin Capital
New York
|
-$3.19M |
